Federated Hermes, Inc. Qiagen N.V. Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$39.13 - $47.24 $504,542 - $609,112	-12,894 Reduced 91.9%	1,136 $46,000
Q2 2023 Aug 14, 2023	BUY	$43.93 - $46.76 $127,968 - $136,211	2,913 Added 26.2%	14,030 $631,000
Q1 2023 May 08, 2023	SELL	$45.29 - $50.76 $114,040 - $127,813	-2,518 Reduced 18.47%	11,117 $510,000
Q4 2022 Feb 13, 2023	BUY	$41.91 - $50.48 $307,619 - $370,523	7,340 Added 116.6%	13,635 $680,000
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $24,867 - $30,655	-608 Reduced 8.81%	6,295 $260,000
Q2 2022 Aug 15, 2022	BUY	$42.98 - $49.77 $296,690 - $343,562	6,903 New	6,903 $326,000

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.4B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.